Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples

Saved in:
Bibliographic Details
Published inLeukemia & lymphoma Vol. 57; no. 8; pp. 1938 - 1941
Main Authors Lu, Benjamin Y., Thanawala, Shivani U., Zochowski, Kelly C., Burke, Michael J, Carroll, William L., Bhatla, Teena
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 02.08.2016
Subjects
Animals
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - pharmacology
Antineoplastic Combined Chemotherapy Protocols - pharmacology
Azacitidine - administration & dosage
Azacitidine - analogs & derivatives
Azacitidine - pharmacology
Basic Helix-Loop-Helix Transcription Factors - genetics
Cell Line, Tumor
Cell Survival - drug effects
Cell Survival - genetics
Decitabine
Drug Synergism
Gene Expression Regulation, Leukemic - drug effects
Humans
Jurkat Cells
Mice
Neoplasm Proteins - genetics
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology
Receptors, Interleukin-7 - genetics
Reverse Transcriptase Polymerase Chain Reaction
Xenograft Model Antitumor Assays
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1042-8194
1029-2403
DOI:10.3109/10428194.2015.1110747